ReviewImmunity, inflammation and disease2022

SARS-CoV-2 targeting by RNAi and host complement inhibition: A two-pronged subterfuge for COVID-19 treatment.

Raza Ali Naqvi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.